These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
600 related items for PubMed ID: 2401074
1. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA. Circulation; 1990 Oct; 82(4):1424-37. PubMed ID: 2401074 [Abstract] [Full Text] [Related]
2. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. De Coster PM, Wijns W, Cauwe F, Robert A, Beckers C, Melin JA. Circulation; 1990 Dec; 82(6):2152-62. PubMed ID: 2242539 [Abstract] [Full Text] [Related]
3. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. Sinusas AJ, Watson DD, Cannon JM, Beller GA. J Am Coll Cardiol; 1989 Dec; 14(7):1785-93. PubMed ID: 2584570 [Abstract] [Full Text] [Related]
4. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion. Beller GA, Glover DK, Edwards NC, Ruiz M, Simanis JP, Watson DD. Circulation; 1993 Jun; 87(6):2033-42. PubMed ID: 8504518 [Abstract] [Full Text] [Related]
5. Impact of regional ventricular function, geometry, and dobutamine stress on quantitative 99mTc-sestamibi defect size. Sinusas AJ, Shi Q, Vitols PJ, Fetterman RC, Maniawski P, Zaret BL, Wackers FJ. Circulation; 1993 Nov; 88(5 Pt 1):2224-34. PubMed ID: 8222117 [Abstract] [Full Text] [Related]
6. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion. Chareonthaitawee P, O'Connor MK, Gibbons RJ, Ritman EL, Christian TF. Eur J Nucl Med; 2000 May; 27(5):508-16. PubMed ID: 10853805 [Abstract] [Full Text] [Related]
7. Relations of the myocardial imaging agents 99mTc-MIBI and 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult. Canby RC, Silber S, Pohost GM. Circulation; 1990 Jan; 81(1):289-96. PubMed ID: 2137046 [Abstract] [Full Text] [Related]
8. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Sansoy V, Glover DK, Watson DD, Ruiz M, Smith WH, Simanis JP, Beller GA. Circulation; 1995 Aug 15; 92(4):994-1004. PubMed ID: 7641384 [Abstract] [Full Text] [Related]
9. Assessment of perfused left ventricular mass in normal, ischemic, and reperfused myocardium by means of single-photon emission computed tomography of technetium-99m isonitrile. Wolfe CL, O'Connell JW, Sievers RE, Cobb C, Dae MW, Botvinick E. Am Heart J; 1993 Dec 15; 126(6):1275-86. PubMed ID: 8249782 [Abstract] [Full Text] [Related]
10. Effect of coronary reperfusion on technetium-99m methoxyisobutylisonitrile uptake by viable and necrotic myocardium in the dog. Merhi Y, Latour JG, Arsenault A, Rousseau G. Eur J Nucl Med; 1992 Dec 15; 19(7):503-10. PubMed ID: 1644107 [Abstract] [Full Text] [Related]
11. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Glover DK, Okada RD. Circulation; 1990 Feb 15; 81(2):628-37. PubMed ID: 2297867 [Abstract] [Full Text] [Related]
12. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Circulation; 1993 Aug 15; 88(2):596-604. PubMed ID: 8339423 [Abstract] [Full Text] [Related]
13. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion. Glover DK, Ruiz M, Koplan BA, Watson DD, Beller GA. J Nucl Med; 1999 Jan 15; 40(1):142-9. PubMed ID: 9935070 [Abstract] [Full Text] [Related]
14. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis. Sinusas AJ, Bergin JD, Edwards NC, Watson DD, Ruiz M, Makuch RW, Smith WH, Beller GA. Circulation; 1994 May 15; 89(5):2332-41. PubMed ID: 8181159 [Abstract] [Full Text] [Related]
15. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, Bolli R. J Am Coll Cardiol; 1988 Dec 15; 12(6):1573-81. PubMed ID: 2973483 [Abstract] [Full Text] [Related]
16. Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging. Pfisterer M, Müller-Brand J, Spring P, Bassignana V, Kiowski W. Am Heart J; 1991 Jul 15; 122(1 Pt 1):7-12. PubMed ID: 1829571 [Abstract] [Full Text] [Related]
17. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Okada RD, Glover D, Gaffney T, Williams S. Circulation; 1988 Feb 15; 77(2):491-8. PubMed ID: 3338137 [Abstract] [Full Text] [Related]
18. Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after coronary reperfusion despite the presence of severe residual stenosis. Takehana K, Ruiz M, Petruzella FD, Watson DD, Beller GA, Glover DK. J Nucl Cardiol; 2001 Feb 15; 8(1):40-8. PubMed ID: 11182708 [Abstract] [Full Text] [Related]
19. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI). Li QS, Solot G, Frank TL, Wagner HN, Becker LC. J Nucl Med; 1990 Jun 15; 31(6):1069-76. PubMed ID: 2140856 [Abstract] [Full Text] [Related]
20. Experimental studies of the physiologic properties of technetium-99m isonitriles. Beller GA, Sinusas AJ. Am J Cardiol; 1990 Oct 16; 66(13):5E-8E. PubMed ID: 2145747 [Abstract] [Full Text] [Related] Page: [Next] [New Search]